Now those investors who missed the growth of stock prices in summer have to look for something to make money on. The time has come to pay attention to pharmaceutical companies again.
COVID-19. Unofficially, we have a vaccine. Officially, we might have it in May.
The S&P500 index is renewing its historical maximums. All seems to go well but analysts keep mentioning yet another wave of crisis that should have come a year ago; however, falling of the stock indices is postponed all the time. In the end, those traders who accumulated short positions are made to close them, pushing the price up.
Falling of Pfizer stocks in April 2019 was used by investors as a good chance to buy them. This time the stocks have fallen again, so let us try to figure out the reasons for this as well as the perspectives of long-term investing in them.
Today, we''ll focus more on technical analysis, using fundamentals only to confirm the tech analysis result or prove it wrong. In practice, tech analysis often predicts the events the retail investors are not aware of.